Hematologic manifestations of Helicobacter pylori infection

World Journal of Gastroenterology

Volumn 20, Issue 36, 2014, Pages 12818-12838

  Campuzano Maya, Germán ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Helicobacter pylori; Immune thrombocytopenia; Iron deficiency; Mucosa associated lymphoid tissue lymphoma; Vitamin B12 deficiency

Indexed keywords

CYANOCOBALAMIN; IRON;

ABDOMINAL RADIOTHERAPY; ANAPHYLACTOID PURPURA; ANTIPHOSPHOLIPID SYNDROME; CANCER CHEMOTHERAPY; CHILDHOOD LEUKEMIA; CYANOCOBALAMIN DEFICIENCY; GASTRECTOMY; HELICOBACTER INFECTION; HEMATOLOGIC DISEASE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; MARGINAL ZONE LYMPHOMA; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; PATHOPHYSIOLOGY; PLASMA CELL DYSCRASIA; REVIEW; THROMBOCYTOSIS; VITAMIN SUPPLEMENTATION; ANIMAL; BLOOD; COMPLICATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEMATOLOGIC DISEASES; MICROBIOLOGY; PATHOGENICITY; PROGNOSIS; RISK FACTOR;

ANIMALS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEMATOLOGIC DISEASES; HUMANS; PROGNOSIS; RISK FACTORS;

EID: 84928399464     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i36.12818     Document Type: Review

References (323)

1. Mitchell HM. The epidemiology of Helicobacter pylori. Curr Top Microbiol Immunol 1999; 241: 11-30 [PMID: 10087654 DOI: 10.1007/978-3-642-60013-5-2]
2. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group. Gut 1993; 34: 1672-1676 [PMID: 8282253 DOI: 10.1136/gut.34.12.1672]
3. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273-1275 [PMID: 6134060]
4. Correa P. Gastric cancer: overview. Gastroenterol Clin North Am 2013; 42: 211-217 [PMID: 23639637 DOI: 10.1016/j.gtc.2013.01.002]
5. Stolte M, Bayerdörffer E, Morgner A, Alpen B, Wündisch T, Thiede C, Neubauer A. Helicobacter and gastric MALT lymphoma. Gut 2002; 50 Suppl 3: III19-III24 [PMID: 11953328 DOI: 10.1136/gut.50.suppl-3.iii19]
6. Gasbarrini A, Franceschi F, Armuzzi A, Ojetti V, Candelli M, Torre ES, De Lorenzo A, Anti M, Pretolani S, Gasbarrini G. Extradigestive manifestations of Helicobacter pylori gastric infection. Gut 1999; 45 Suppl 1: I9-I12 [PMID: 10457029 DOI: 10.1136/gut.45.2008.i9]
7. Realdi G, Dore MP, Fastame L. Extradigestive manifestations of Helicobacter pylori infection: fact and fiction. Dig Dis Sci 1999; 44: 229-236 [PMID: 10063905 DOI: 10.1023/A:1026677728175]
8. Carloni E, Cremonini F, Di Caro S, Padalino C, Gerardino L, Santoliquido A, Colasanti S, Pola P, Gasbarrini A. Helicobacter pylori-related extradigestive diseases and effects of eradication therapy. Dig Liver Dis 2000; 32 Suppl 3: S214-S216 [PMID: 11245299 DOI: 10.1016/S1590-8658(00)80282-0]
9. De Koster E, De Bruyne I, Langlet P, Deltenre M. Evidence based medicine and extradigestive manifestations of Helicobacter pylori. Acta Gastroenterol Belg 2000; 63: 388-392 [PMID: 11233523]
10. Sherman PM, Lin FY. Extradigestive manifestation of Helicobacter pylori infection in children and adolescents. Can J Gastroenterol 2005; 19: 421-424 [PMID: 16010304]
11. Solnick JV, Franceschi F, Roccarina D, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection - other Helicobacter species. Helicobacter 2006; 11 Suppl 1: 46-51 [PMID: 16925612 DOI: 10.1111/j.1478-405X.2006.00430.x]
12. Bohr UR, Annibale B, Franceschi F, Roccarina D, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection - other Helicobacters. Helicobacter 2007; 12 Suppl 1: 45-53 [PMID: 17727460 DOI: 10.1111/j.1523-5378.2007.00533.x]
13. Moyaert H, Franceschi F, Roccarina D, Ducatelle R, Haesebrouck F, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection: other Helicobacters. Helicobacter 2008; 13 Suppl 1: 47-57 [PMID: 18783522]
14. Pellicano R, Franceschi F, Saracco G, Fagoonee S, Roccarina D, Gasbarrini A. Helicobacters and extragastric diseases. Helicobacter 2009; 14 Suppl 1: 58-68 [PMID: 19712170 DOI: 10.1111/j.1523-5378.2009.00699.x]
15. Figura N, Franceschi F, Santucci A, Bernardini G, Gasbarrini G, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. Helicobacter 2010; 15 Suppl 1: 60-68 [PMID: 21054655 DOI: 10.1111/j.1523-5378.2010.00778.x]
16. Suzuki H, Franceschi F, Nishizawa T, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. Helicobacter 2011; 16 Suppl 1: 65-69 [PMID: 21896088 DOI: 10.1111/j.1523-5378.2011.00883.x]
17. Banić M, Franceschi F, Babić Z, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. Helicobacter 2012; 17 Suppl 1: 49-55 [PMID: 22958156 DOI: 10.1111/j.1523-5378.2012.00983.x]
18. Roubaud Baudron C, Franceschi F, Salles N, Gasbarrini A. Extragastric diseases and Helicobacter pylori. Helicobacter 2013; 18 Suppl 1: 44-51 [PMID: 24011245 DOI: 10.1111/hel.12077]
19. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El- Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-781 [PMID: 17170018]
20. Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007; 102: 1808-1825 [PMID: 17608775 DOI: 10.1111/j.1572-0241.2007.01393.x]
21. Caselli M, Zullo A, Maconi G, Parente F, Alvisi V, Casetti T, Sorrentino D, Gasbarrini G. "Cervia II Working Group Report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy. Dig Liver Dis 2007; 39: 782-789 [PMID: 17606419 DOI: 10.1016/j.dld.2007.05.016]
22. Kim N, Kim JJ, Choe YH, Kim HS, Kim JI, Chung IS. [Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea]. Korean J Gastroenterol 2009; 54: 269-278 [PMID: 19934608 DOI: 10.4166/kjg.2009.54.5.269]
23. Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, Lam SK, Xiao SD, Tan HJ, Wu CY, Jung HC, Hoang BH, Kachintorn U, Goh KL, Chiba T, Rani AA. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009; 24: 1587-1600 [PMID: 19788600]
24. Asaka M, Kato M, Takahashi S, Fukuda Y, Sugiyama T, Ota H, Uemura N, Murakami K, Satoh K, Sugano K. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 2010; 15: 1-20 [PMID: 20302585]
25. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ. Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report. Gut 2012; 61: 646-664 [PMID: 22491499 DOI: 10.1136/gutjnl-2012-302084]
26. Coelho LG, Maguinilk I, Zaterka S, Parente JM, do Carmo Friche Passos M, Moraes-Filho JP. 3rd Brazilian Consensus on Helicobacter pylori. Arq Gastroenterol 2013; 50: [PMID: 23748591 DOI: 10.1590/S0004-28032013005000001]
27. Gisbert JP, Calvet X, Bermejo F, Boixeda D, Bory F, Bujanda L, Castro-Fernández M, Dominguez-Muñoz E, Elizalde JI, Forné M, Gené E, Gomollón F, Lanas Á, Martín de Argila C, McNicholl AG, Mearin F, Molina-Infante J, Montoro M, Pajares JM, Pérez-Aisa A, Pérez-Trallero E, Sánchez-Delgado J. [III Spanish Consensus Conference on Helicobacter pylori infection]. Gastroenterol Hepatol 2013; 36: 340-374 [PMID: 23601856 DOI: 10.1016/j.gastrohep.2013.01.011]
28. Liu WZ, Xie Y, Cheng H, Lu NH, Hu FL, Zhang WD, Zhou LY, Chen Y, Zeng ZR, Wang CW, Xiao SD, Pan GZ, Hu PJ. Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection. J Dig Dis 2013; 14: 211-221 [PMID: 23302262 DOI: 10.1111/1751-2980.12034]
29. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group. Gut 1997; 41: 8-13 [PMID: 9274464 DOI: 10.1136/gut.41.1.8]
30. Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998; 13: 1-12 [PMID: 9737564 DOI: 10.1111/j.1440-1746.1998.tb00537.x]
31. Sainz R, Borda F, Domínguez E, Gisbert JP. [Helicobacter pylori infection. The Spanish consensus report. The Spanish Consensus Conference Group]. Rev Esp Enferm Dig 1999; 91: 777-784 [PMID: 10601771]
32. Coelho LG, León-Barúa R, Quigley EM. Latin-American Consensus Conference on Helicobacter pylori infection. Latin-American National Gastroenterological Societies affiliated with the Inter-American Association of Gastroenterology (AIGE). Am J Gastroenterol 2000; 95: 2688-2691 [PMID: 11051336 DOI: 10.1111/j.1572-0241.2000.03174.x]
33. Caselli M, Parente F, Palli D, Covacci A, Alvisi V, Gasbarrini G, Bianchi Porro G. "Cervia Working Group Report": guidelines on the diagnosis and treatment of Helicobacter pylori infection. Dig Liver Dis 2001; 33: 75-80 [PMID: 11303980 DOI: 10.1016/S1590-8658(01)80139-0]
34. Malfertheiner P, Mégraud F, O'Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-180 [PMID: 11860399 DOI: 10.1046/j.1365-2036.2002.01169.x]
35. Coelho LG, Zaterka S. [Second Brazilian Consensus Conference on Helicobacter pylori infection]. Arq Gastroenterol 2005; 42: 128-132 [PMID: 16127570]
36. Monés J, Gisbert JP, Borda F, Domínguez-Muñoz E. Indications, diagnostic tests and Helicobacter pylori eradication therapy. Recommendations by the 2nd Spanish Consensus Conference. Rev Esp Enferm Dig 2005; 97: 348-374 [PMID: 16004527 DOI: 10.4321/S1130-01082005000500007]
37. Hu FL, Hu PJ, Liu WZ, De Wang J, Lv NH, Xiao SD, Zhang WD, Cheng H, Xie Y. Third Chinese National Consensus Report on the management of Helicobacter pylori infection. J Dig Dis 2008; 9: 178-184 [PMID: 18956598 DOI: 10.1111/j.1751-2980.2008.00342.x]
38. WHO/UNICEF/UNU. Iron deficiency anemia assessment, prevention, and control. Geneva: World Health Organization. Available: http://www.who.int/nutrition/publications/en/ida-assessment-prevention-control.pdf
39. McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr 2009; 12: 444-454 [PMID: 18498676 DOI: 10.1017/S1368980008002401]
40. Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet 2007; 370: 511-520 [PMID: 17693180 DOI: 10.1016/S0140-6736(07)61235-5]
41. Goodnough LT, Nemeth E. Iron deficiency and related disorders. In: Greer JP, Arber DA, Glader B, List AF, Means RTJ, Paraskevas F, Rodgers GM, editors. Wintrobe's Clinical Hema-tology. 13th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2013: 617-642
42. Blecker U, Renders F, Lanciers S, Vandenplas Y. Syncopes leading to the diagnosis of a Helicobacter pylori positive chronic active haemorrhagic gastritis. Eur J Pediatr 1991; 150: 560-561 [PMID: 1954961 DOI: 10.1007/BF02072207]
43. Bruel H, Dabadie A, Pouedras P, Gambert C, Le Gall E, Jezequel C. [Helicobacter pylori gastritis manifested by acute anemia]. Ann Pediatr (Paris) 1993; 40: 364-367 [PMID: 8352498]
44. Dufour C, Brisigotti M, Fabretti G, Luxardo P, Mori PG, Barabino A. Helicobacter pylori gastric infection and sideropenic refractory anemia. J Pediatr Gastroenterol Nutr 1993; 17: 225-227 [PMID: 8229554 DOI: 10.1097/00005176-199308000-00018]
45. Marignani M, Angeletti S, Bordi C, Malagnino F, Mancino C, Delle Fave G, Annibale B. Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection. Scand J Gastroenterol 1997; 32: 617-622 [PMID: 9200297 DOI: 10.3109/00365529709025109]
46. Milman N, Rosenstock S, Andersen L, Jørgensen T, Bonnevie O. Serum ferritin, hemoglobin, and Helicobacter pylori infection: a seroepidemiologic survey comprising 2794 Danish adults. Gastroenterology 1998; 115: 268-274 [PMID: 9679031 DOI: 10.1016/S0016-5085(98)70192-1]
47. Annibale B, Marignani M, Monarca B, Antonelli G, Marcheggiano A, Martino G, Mandelli F, Caprilli R, Delle Fave G. Reversal of iron deficiency anemia after Helicobacter pylori eradication in patients with asymptomatic gastritis. Ann Intern Med 1999; 131: 668-672 [PMID: 10577329]
48. Barabino A, Dufour C, Marino CE, Claudiani F, De Alessandri A. Unexplained refractory iron-deficiency anemia associated with Helicobacter pylori gastric infection in children: further clinical evidence. J Pediatr Gastroenterol Nutr 1999; 28: 116-119 [PMID: 9890483 DOI: 10.1097/00005176-199901000-00027]
49. Capurso G, Marignani M, Delle Fave G, Annibale B. Irondeficiency anemia in premenopausal women: why not consider atrophic body gastritis and Helicobacter pylori role? Am J Gastroenterol 1999; 94: 3084-3085 [PMID: 10520890 DOI: 10.1111/j.1572-0241.1999.03084.x]
50. Peach HG, Bath NE, Farish SJ. Helicobacter pylori infection: an added stressor on iron status of women in the community. Med J Aust 1998; 169: 188-190 [PMID: 9734575]
51. Collett JA, Burt MJ, Frampton CM, Yeo KH, Chapman TM, Buttimore RC, Cook HB, Chapman BA. Seroprevalence of Helicobacter pylori in the adult population of Christchurch: risk factors and relationship to dyspeptic symptoms and iron studies. N Z Med J 1999; 112: 292-295 [PMID: 10493426]
52. Muhsen K, Cohen D. Helicobacter pylori infection and iron stores: a systematic review and meta-analysis. Helicobacter 2008; 13: 323-340 [PMID: 19250507]
53. Qu XH, Huang XL, Xiong P, Zhu CY, Huang YL, Lu LG, Sun X, Rong L, Zhong L, Sun DY, Lin H, Cai MC, Chen ZW, Hu B, Wu LM, Jiang YB, Yan WL. Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis. World J Gastroenterol 2010; 16: 886-896 [PMID: 20143469]
54. Huang X, Qu X, Yan W, Huang Y, Cai M, Hu B, Wu L, Lin H, Chen Z, Zhu C, Lu L, Sun X, Rong L, Jiang Y, Sun D, Zhong L, Xiong P. Iron deficiency anaemia can be improved after eradication of Helicobacter pylori. Postgrad Med J 2010; 86: 272-278 [PMID: 20448223]
55. Yuan W, Li Yumin D, Yang L. Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trials. Scand J Gastroenterol 2010; 45: 665-676 [PMID: 20201716 DOI: 10.3109/00365521003663670]
56. Zhang ZF, Yang N, Zhao G, Zhu L, Zhu Y, Wang LX. Effect of Helicobacter pylori eradication on iron deficiency. Chin Med J (Engl) 2010; 123: 1924-1930 [PMID: 20819579]
57. Ashorn M, Ruuska T, Mäkipernaa A. Helicobacter pylori and iron deficiency anaemia in children. Scand J Gastroenterol 2001; 36: 701-705 [PMID: 11444468]
58. Seo JK, Ko JS, Choi KD. Serum ferritin and Helicobacter pylori infection in children: a sero-epidemiologic study in Korea. J Gastroenterol Hepatol 2002; 17: 754-757 [PMID: 12121504]
59. Kostaki M, Fessatou S, Karpathios T. Refractory iron-deficiency anaemia due to silent Helicobacter pylori gastritis in children. Eur J Pediatr 2003; 162: 177-179 [PMID: 12655422]
60. Yang YJ, Sheu BS, Lee SC, Yang HB, Wu JJ. Children of Helicobacter pylori-infected dyspeptic mothers are predisposed to H. pylori acquisition with subsequent iron deficiency and growth retardation. Helicobacter 2005; 10: 249-255 [PMID: 15904483]
61. Gessner BD, Baggett HC, Muth PT, Dunaway E, Gold BD, Feng Z, Parkinson AJ. A controlled, household-randomized, open-label trial of the effect that treatment of Helicobacter pylori infection has on iron deficiency in children in rural Alaska. J Infect Dis 2006; 193: 537-546 [PMID: 16425133]
62. Baggett HC, Parkinson AJ, Muth PT, Gold BD, Gessner BD. Endemic iron deficiency associated with Helicobacter pylori infection among school-aged children in Alaska. Pediatrics 2006; 117: e396-e404 [PMID: 16452320]
63. Süoglu OD, Gökc¸e S, Saglam AT, Sökücü S, Saner G. Association of Helicobacter pylori infection with gastroduodenal disease, epidemiologic factors and iron-deficiency anemia in Turkish children undergoing endoscopy, and impact on growth. Pediatr Int 2007; 49: 858-863 [PMID: 18045286]
64. Sarker SA, Mahmud H, Davidsson L, Alam NH, Ahmed T, Alam N, Salam MA, Beglinger C, Gyr N, Fuchs GJ. Causal relationship of Helicobacter pylori with iron-deficiency anemia or failure of iron supplementation in children. Gastroenterology 2008; 135: 1534-1542 [PMID: 18775429]
65. Haghi-Ashtiani MT, Monajemzadeh M, Motamed F, Mahjoub F, Sharifan M, Shahsiah R, Kashef N. Anemia in children with and without Helicobacter pylori infection. Arch Med Res 2008; 39: 536-540 [PMID: 18514100]
66. Choe YH, Lee JE, Kim SK. Effect of helicobacter pylori eradication on sideropenic refractory anaemia in adolescent girls with Helicobacter pylori infection. Acta Paediatr 2000; 89: 154-157 [PMID: 10709883]
67. Choe YH, Kim SK, Hong YC. The relationship between Helicobacter pylori infection and iron deficiency: seroprevalence study in 937 pubescent children. Arch Dis Child 2003; 88: 178 [PMID: 12538339]
68. Hershko C, Hoffbrand AV, Keret D, Souroujon M, Maschler I, Monselise Y, Lahad A. Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia. Haematologica 2005; 90: 585-595 [PMID: 15921373]
69. Parkinson AJ, Gold BD, Bulkow L, Wainwright RB, Swaminathan B, Khanna B, Petersen KM, Fitzgerald MA. High prevalence of Helicobacter pylori in the Alaska native population and association with low serum ferritin levels in young adults. Clin Diagn Lab Immunol 2000; 7: 885-888 [PMID: 11063492]
70. Berg G, Bode G, Blettner M, Boeing H, Brenner H. Helicobacter pylori infection and serum ferritin: A populationbased study among 1806 adults in Germany. Am J Gastroenterol 2001; 96: 1014-1018 [PMID: 11316140]
71. Bini EJ. Helicobacter pylori and iron deficiency anemia: guilty as charged? Am J Med 2001; 111: 495-497 [PMID: 11690578]
72. Cuoco L, Cammarota G, Jorizzo RA, Santarelli L, Cianci R, Montalto M, Gasbarrini A, Gasbarrini G. Link between Helicobacter pylori infection and iron-deficiency anaemia in patients with coeliac disease. Scand J Gastroenterol 2001; 36: 1284-1288 [PMID: 11761018]
73. Choe YH, Kwon YS, Jung MK, Kang SK, Hwang TS, Hong YC. Helicobacter pylori-associated iron-deficiency anemia in adolescent female athletes. J Pediatr 2001; 139: 100-104 [PMID: 11445801]
74. Yoshimura M, Hirai M, Tanaka N, Kasahara Y, Hosokawa O. Remission of severe anemia persisting for over 20 years after eradication of Helicobacter pylori in cases of Ménètrier's disease and atrophic gastritis: Helicobacter pylori as a pathogenic factor in iron-deficiency anemia. Intern Med 2003; 42: 971-977 [PMID: 14606710]
75. Nahon S, Lahmek P, Massard J, Lesgourgues B, Mariaud de Serre N, Traissac L, Bodiguel V, Adotti F, Delas N. Helicobacter pylori-associated chronic gastritis and unexplained iron deficiency anemia: a reliable association? Helicobacter 2003; 8: 573-577 [PMID: 14632670]
76. Ciacci C, Sabbatini F, Cavallaro R, Castiglione F, Di Bella S, Iovino P, Palumbo A, Tortora R, Amoruso D, Mazzacca G. Helicobacter pylori impairs iron absorption in infected individuals. Dig Liver Dis 2004; 36: 455-460 [PMID: 15285524]
77. Valiyaveettil AN, Hamide A, Bobby Z, Krishnan R. Effect of anti-Helicobacter pylori therapy on outcome of irondeficiency anemia: a randomized, controlled study. Indian J Gastroenterol 2005; 24: 155-157 [PMID: 16204902]
78. Cardenas VM, Mulla ZD, Ortiz M, Graham DY. Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol 2006; 163: 127-134 [PMID: 16306309]
79. Chen LH, Luo HS. Effects of H pylori therapy on erythrocytic and iron parameters in iron deficiency anemia patients with H pylori-positive chronic gastristis. World J Gastroenterol 2007; 13: 5380-5383 [PMID: 17879411]
80. Vijayan G, Sundaram RC, Bobby Z, Hamide A, Selvaraj N, Dasse NR. Increased plasma malondialdehyde and fructosamine in anemic H pylori infected patients: effect of treatment. World J Gastroenterol 2007; 13: 796-800 [PMID: 17278206]
81. Kaffes A, Cullen J, Mitchell H, Katelaris PH. Effect of Helicobacter pylori infection and low-dose aspirin use on iron stores in the elderly. J Gastroenterol Hepatol 2003; 18: 1024-1028 [PMID: 12911657]
82. Mulayim B, Celik NY, Yanik FF. Helicobacter pylori infection detected by 14C-urea breath test is associated with iron deficiency anemia in pregnant women. J Obstet Gynaecol Res 2008; 34: 980-985 [PMID: 19012696]
83. Correa P, Piazuelo MB. Natural history of Helicobacter pylori infection. Dig Liver Dis 2008; 40: 490-496 [PMID: 18396115]
84. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001; 276: 7806-7810 [PMID: 11113131 DOI: 10.1074/jbc.M008922200]
85. Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW. Hepcidin in human iron disorders: diagnostic implications. Clin Chem 2011; 57: 1650-1669 [PMID: 21989113 DOI: 10.1373/clinchem.2009.140053]
86. Cherian S, Forbes DA, Cook AG, Sanfilippo FM, Kemna EH, Swinkels DW, Burgner DP. An insight into the relationships between hepcidin, anemia, infections and inflammatory cytokines in pediatric refugees: a cross-sectional study. PLoS One 2008; 3: e4030 [PMID: 19107209 DOI: 10.1371/journal.pone.0004030]
87. Hershko C, Ronson A. Iron deficiency, Helicobacter infection and gastritis. Acta Haematol 2009; 122: 97-102 [PMID: 19907146]
88. Lee SY, Song EY, Yun YM, Yoon SY, Cho YH, Kim SY, Lee MH. Serum prohepcidin levels in Helicobacter pylori infected patients with iron deficiency anemia. Korean J Intern Med 2010; 25: 195-200 [PMID: 20526394 DOI: 10.3904/kjim.2010.25.2.195]
89. Schwarz P, Kübler JA, Strnad P, Müller K, Barth TF, Gerloff A, Feick P, Peyssonnaux C, Vaulont S, Adler G, Kulaksiz H. Hepcidin is localised in gastric parietal cells, regulates acid secretion and is induced by Helicobacter pylori infection. Gut 2012; 61: 193-201 [PMID: 21757452 DOI: 10.1136/gut.2011.241208]
90. Ozkasap S, Yarali N, Isik P, Bay A, Kara A, Tunc B. The role of prohepcidin in anemia due to Helicobacter pylori infection. Pediatr Hematol Oncol 2013; 30: 425-431 [PMID: 23560993 DOI: 10.3109/08880018.2013.783144]
91. Azab SF, Esh AM. Serum hepcidin levels in Helicobacter pylori-infected children with iron-deficiency anemia: a case-control study. Ann Hematol 2013; 92: 1477-1483 [PMID: 23760782 DOI: 10.1007/s00277-013-1813-2]
92. Yip R, Limburg PJ, Ahlquist DA, Carpenter HA, O'Neill A, Kruse D, Stitham S, Gold BD, Gunter EW, Looker AC, Parkinson AJ, Nobmann ED, Petersen KM, Ellefson M, Schwartz S. Pervasive occult gastrointestinal bleeding in an Alaska native population with prevalent iron deficiency. Role of Helicobacter pylori gastritis. JAMA 1997; 277: 1135-1139 [PMID: 9087468]
93. Kang JM, Kim N, Lee BH, Park HK, Jo HJ, Shin CM, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Jung HC, Song IS. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents. Scand J Gastroenterol 2011; 46: 1295-1301 [PMID: 21815866 DOI: 10.3109/00365521.2011.605468]
94. Musumba C, Jorgensen A, Sutton L, Van Eker D, Moorcroft J, Hopkins M, Pritchard DM, Pirmohamed M. The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010. Aliment Pharmacol Ther 2012; 36: 48-56 [PMID: 22554233 DOI: 10.1111/j.1365-2036.2012.05118.x]
95. Vergara M, Catalán M, Gisbert JP, Calvet X. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment Pharmacol Ther 2005; 21: 1411-1418 [PMID: 15948807]
96. De Leest HT, Steen KS, Bloemena E, Lems WF, Kuipers EJ, Van de Laar MA, Bijlsma JW, Janssen M, Houben HH, Kostense PJ, Boers M, Dijkmans BA. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial. J Clin Gastroenterol 2009; 43: 140-146 [PMID: 18797408 DOI: 10.1097/MCG.0b013e3181595b40]
97. Sokic-Milutinovic A, Krstic M, Rozer-Smolovic B, Alempijevic T. Role of Helicobacter pylori infection in gastroduodenal damage in patients starting NSAID therapy: 4 Months follow-up study. Dig Dis Sci 2010; 55: 2887-2892 [PMID: 20094785 DOI: 10.1007/s10620-009-1097-5]
98. Song HJ, Kwon JW, Kim N, Park YS. Cost Effectiveness Associated with Helicobacter pylori Screening and Eradication in Patients Taking Nonsteroidal Anti-Inflammatory Drugs and/or Aspirin. Gut Liver 2013; 7: 182-189 [PMID: 23560154 DOI: 10.5009/gnl.2013.7.2.182]
99. Afifi MT, Abd El-Aziz HK, Hamed NA, Barghash NA, Abdo A, Gamal M. Role of Helicobacter pylori in refractory iron deficiency anaemia. Br J Biomed Sci 2009; 66: 133-136 [PMID: 19839223]
100. Boyanova L. Role of Helicobacter pylori virulence factors for iron acquisition from gastric epithelial cells of the host and impact on bacterial colonization. Future Microbiol 2011; 6: 843-846 [PMID: 21861616 DOI: 10.2217/fmb.11.75]
101. Ge R, Sun X. Iron trafficking system in Helicobacter pylori. Biometals 2012; 25: 247-258 [PMID: 22127376 DOI: 10.1007/s10534-011-9512-8]
102. Davis RE. Clinical chemistry of vitamin B12. Adv Clin Chem 1985; 24: 163-216 [PMID: 3911750]
103. Andrès E, Loukili NH, Noel E, Kaltenbach G, Abdelgheni MB, Perrin AE, Noblet-Dick M, Maloisel F, Schlienger JL, Blicklé JF. Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ 2004; 171: 251-259 [PMID: 15289425]
104. Dali-Youcef N, Andrès E. An update on cobalamin deficiency in adults. QJM 2009; 102: 17-28 [PMID: 18990719 DOI: 10.1093/qjmed/hcn138]
105. Herbert V. Staging vitamin B-12 (cobalamin) status in vegetarians. Am J Clin Nutr 1994; 59: 1213S-1222S [PMID: 8172125]
106. Carmel R, Johnson CS, Weiner JM. Pernicious anemia in Latin Americans is not a disease of the elderly. Arch Intern Med 1987; 147: 1995-1996 [PMID: 3675102]
107. Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med 1996; 156: 1097-1100 [PMID: 8638997]
108. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D' Agostino RB, Wilson PW, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346: 476-483 [PMID: 11844848]
109. Hooshmand B, Solomon A, Ka˚reholt I, Leiviskä J, Rusanen M, Ahtiluoto S, Winblad B, Laatikainen T, Soininen H, Kivipelto M. Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study. Neurology 2010; 75: 1408-1414 [PMID: 20956786 DOI: 10.1212/WNL.0b013e3181f88162]
110. Werder SF. Cobalamin deficiency, hyperhomocysteinemia, and dementia. Neuropsychiatr Dis Treat 2010; 6: 159-195 [PMID: 20505848]
111. Hooshmand B, Solomon A, Ka˚reholt I, Rusanen M, Hänninen T, Leiviskä J, Winblad B, Laatikainen T, Soininen H, Kivipelto M. Associations between serum homocysteine, holotranscobalamin, folate and cognition in the elderly: a longitudinal study. J Intern Med 2012; 271: 204-212 [PMID: 22077644 DOI: 10.1111/j.1365-2796.2011.02484.x]
112. Tiemeier H, van Tuijl HR, Hofman A, Meijer J, Kiliaan AJ, Breteler MM. Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Am J Psychiatry 2002; 159: 2099-2101 [PMID: 12450964]
113. Kaptan K, Beyan C. Does hyperhomocysteinemia due to vitamin B12 deficiency associted with Helicobacter pylori infection has a role on cerebral stroke? Med Sci Monit 2002; 8: LE52-LE3; author reply LE53 [PMID: 12546023]
114. Moghaddasi M, Mamarabadi M, Mirzadeh S, Freydoonnejad AA, Razjouyan H. Homocysteine, vitamin B12 and folate levels in Iranian patients with ischemic stroke. Neurol Res 2010; 32: 953-956 [PMID: 20433777 DOI: 10.1179/016164110X 12644252260475]
115. Caldera A, Mora J, Kotler M, Eiger G. Pulmonary embolism in a patient with pernicious anemia and hyperhomocysteinemia. Chest 2002; 122: 1487-1488 [PMID: 12377886]
116. Andrès E, Kurtz JE. Pulmonary embolism in pernicious anemia and hyperhomocysteinemia. Chest 2003; 124: 1181 [PMID: 12970061]
117. Whincup PH, Mendall MA, Perry IJ, Strachan DP. Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease. Heart 1997; 78: 524 [PMID: 9415019]
118. O'Connor HJ, Axon AT, Dixon MF. Campylobacter-like organisms unusual in type A (pernicious anaemia) gastritis. Lancet 1984; 2: 1091 [PMID: 6150156]
119. Fong TL, Dooley CP, Dehesa M, Cohen H, Carmel R, Fitzgibbons PL, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology 1991; 100: 328-332 [PMID: 1985031]
120. Saito M, Mori A, Irie T, Tanaka M, Morioka M. [Helicobacter pylori infection is not associated with pernicious anemia in Japan]. Rinsho Ketsueki 2008; 49: 1569-1571 [PMID: 19047791]
121. Kokkola A, Kosunen TU, Puolakkainen P, Sipponen P, Harkonen M, Laxen F, Virtamo J, Haapiainen R, Rautelin H. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS 2003; 111: 619-624 [PMID: 12969017]
122. Suter PM, Golner BB, Goldin BR, Morrow FD, Russell RM. Reversal of protein-bound vitamin B12 malabsorption with antibiotics in atrophic gastritis. Gastroenterology 1991; 101: 1039-1045 [PMID: 1889697]
123. Valle J, Kekki M, Sipponen P, Ihamäki T, Siurala M. Longterm course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 1996; 31: 546-550 [PMID: 8789892]
124. Ma JY, Borch K, Sjöstrand SE, Janzon L, Ma˚rdh S. Positive correlation between H,K-adenosine triphosphatase autoantibodies and Helicobacter pylori antibodies in patients with pernicious anemia. Scand J Gastroenterol 1994; 29: 961-965 [PMID: 7871374]
125. Claeys D, Faller G, Appelmelk BJ, Negrini R, Kirchner T. The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology 1998; 115: 340-347 [PMID: 9679039]
126. Pietroiusti A, Galante A, Magrini A, Bergamaschi A. Helicobacter pylori interference with micronutrients and orally administered drugs: a new mechanism explaining its role in extragastric disorders. Mini Rev Med Chem 2008; 8: 135-141 [PMID: 18289096]
127. Kaptan K, Beyan C, Ural AU, Cetin T, Avcu F, Gülen M, Finci R, Yalc¸ín A. Helicobacter pylori - is it a novel causative agent in Vitamin B12 deficiency? Arch Intern Med 2000; 160: 1349-1353 [PMID: 10809040]
128. Carmel R, Aurangzeb I, Qian D. Associations of food-cobalamin malabsorption with ethnic origin, age, Helicobacter pylori infection, and serum markers of gastritis. Am J Gastroenterol 2001; 96: 63-70 [PMID: 11197289]
129. Andrès E, Federici L, Affenberger S, Vidal-Alaball J, Loukili NH, Zimmer J, Kaltenbach G. B12 deficiency: a look beyond pernicious anemia. J Fam Pract 2007; 56: 537-542 [PMID: 17605945]
130. Lahner E, Persechino S, Annibale B. Micronutrients (Other than iron) and Helicobacter pylori infection: a systematic review. Helicobacter 2012; 17: 1-15 [PMID: 22221610 DOI: 10.1111/j.1523-5378.2011.00892.x]
131. Marino MC, de Oliveira CA, Rocha AM, Rocha GA, Clementino NC, Antunes LF, Oliveira RA, Martins AS, Del Puerto HL, D'Almeida V, Galdieri L, Pedroso ER, Cabral MM, Nogueira AM, Queiroz DM. Long-term effect of Helicobacter pylori eradication on plasma homocysteine in elderly patients with cobalamin deficiency. Gut 2007; 56: 469-474 [PMID: 17005765]
132. Kaplan HS, Rigler LG. Pernicious anemia and susceptibility to gastric neoplasms. J Lab Clin Med 1947; 32: 644-653 [PMID: 20242838]
133. Zamcheck N, Grable E, Ley A, Norman L. Occurrence of gastric cancer among patients with pernicious anemia at the Boston City Hospital. N Engl J Med 1955; 252: 1103-1110 [PMID: 14383972]
134. Berkson J, Butt HR, Comfort MW. Occurrence of gastric cancer in persons with achlorhydria and with pernicious anemia. Proc Staff Meet Mayo Clin 1956; 31: 583-596 [PMID: 13370626]
135. Payne RW. Pernicious anaemia and gastric cancer in England and Wales. Br Med J 1961; 1: 1807-1809 [PMID: 13733686]
136. Vannella L, Lahner E, Osborn J, Annibale B. Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther 2013; 37: 375-382 [PMID: 23216458 DOI: 10.1111/apt.12177]
137. Toh BH, van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med 1997; 337: 1441-1448 [PMID: 9358143]
138. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kühne T, Ruggeri M, George JN. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009; 113: 2386-2393 [PMID: 19005182]
139. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003; 120: 574-596 [PMID: 12588344]
140. Liel MS, Carverley DC. Thrombopcytopenia caused by immunologic platelet destruction. In: Greer JP, Arber DA, Glader B, List AF, Means RTJ, Paraskevas F, Rodgers GM, editors. Wintrobe's Clinical Hematology. 13th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2013: 1061-1076
141. Frederiksen H, Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 1999; 94: 909-913 [PMID: 10419881]
142. Neunert C, Lim W, Crowther M, Cohen A, Solberg L, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011; 117: 4190-4207 [PMID: 21325604 DOI: 10.1182/blood-2010-08-302984]
143. Pizzuto J, Ambriz R. Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: Multicentric Trial of the Cooperative Latin American group on Hemostasis and Thrombosis. Blood 1984; 64: 1179-1183 [PMID: 6388663]
144. García Pérez A, Valverde de La Osa J, Giménez Samper M, Alonso García I. [Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori]. Sangre (Barc) 1999; 44: 387-388 [PMID: 10618919]
145. Tohda S, Ohkusa T. Resolution of refractory idiopathic thrombocytopenic purpura after eradication of Helicobacter pylori. Am J Hematol 2000; 65: 329-330 [PMID: 11074571]
146. Goto H, Kikuta T, Ota A, Tsuji H, Hino R. [Successful treatment of refractory idiopathic thrombocytopenic purpura by eradication of Helicobacter pylori]. Rinsho Ketsueki 2001; 42: 1192-1194 [PMID: 11828723]
147. Mukai M, Kon Y, Notoya A, Kohno M. Helicobacter pylori associated with idiopathic thrombocytopenic purpura. Am J Med 2002; 113: 169-171 [PMID: 12133762]
148. Asaumi N, Niiya K, Shibakura M, Yoshida C, Niiya M, Tanimoto M. Secondary eradication of Helicobacter pylori was effective against refractory idiopathic thrombocytopenic purpura. Blood Coagul Fibrinolysis 2003; 14: 785-786 [PMID: 14614362]
149. Takechi T, Unemoto J, Ishihara M, Hosokawa T, Zushi N, Shiraishi T, Ogura H, Wakiguchi H. Idiopathic thrombocytopenic purpura associated with Helicobacter pylori infection. Pediatr Int 2006; 48: 76-78 [PMID: 16490076]
150. Grimaz S, Damiani D, Brosolo P, Skert C, Geromin A, de Pretis G. Resolution of thrombocytopenia after treatment for Helicobacter pylori: a case report. Haematologica 1999; 84: 283-284 [PMID: 10189400]
151. Soldinger E, Pilia MC, Piubello W, Nadali G. Multi-resistant idiopathic thrombocytopenia successfully treated by eradication of Helicobacter pylori. Dig Liver Dis 2001; 33: 732 [PMID: 11785722 DOI: 10.1016/S1590-8658(01)80053-0]
152. Candelli M, Nista EC, Pignataro G, Gasbarrini G, Gasbarrini A. Idiopathic thrombocytopenic purpura and Helicobacter pylori infection. Scand J Gastroenterol 2003; 38: 569-570 [PMID: 12795473 DOI: 10.1080/00365520310002535]
153. Kurekci AE, Atay AA, Sarici SU, Ozcan O. Complete platelet recovery after treatment of Helicobacter pylori infection in a child with chronic immune thrombocytopenic purpura: a case report. Pediatr Hematol Oncol 2004; 21: 593-596 [PMID: 15626015 DOI: 10.1080/08880010490500962]
154. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998; 352: 878 [PMID: 9742983 DOI: 10.1016/S0140-6736(05)60004-9]
155. Emilia G, Longo G, Luppi M, Gandini G, Morselli M, Ferrara L, Amarri S, Cagossi K, Torelli G. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood 2001; 97: 812-814 [PMID: 11157503 DOI: 10.1182/blood.V97.3.812]
156. Emilia G, Luppi M, Morselli M, Potenza L, D'Apollo N, Torelli G. Helicobacter pylori infection and idiopathic thrombocytopenic purpura. Br J Haematol 2002; 118: 1198-1199 [PMID: 12199816 DOI: 10.1046/j.1365-2141.2002.363010.x]
157. Veneri D, Franchini M, Gottardi M, D'Adda M, Ambrosetti A, Krampera M, Zanetti F, Pizzolo G. Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura. Haematologica 2002; 87: 1177-1179 [PMID: 12414347]
158. Veneri D, Krampera M, Franchini M. High prevalence of sustained remission of idiopathic thrombocytopenic purpura after Helicobacter pylori eradication: a long-term follow-up study. Platelets 2005; 16: 117-119 [PMID: 15823868 DOI: 10.1080/09537100400015153]
159. Stasi R, Rossi Z, Stipa E, Amadori S, Newland AC, Provan D. Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. Am J Med 2005; 118: 414-419 [PMID: 15808140 DOI: 10.1016/ j.amjmed.2004.09.014]
160. Emilia G, Luppi M, Zucchini P, Morselli M, Potenza L, Forghieri F, Volzone F, Jovic G, Leonardi G, Donelli A, Torelli G. Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles. Blood 2007; 110: 3833-3841 [PMID: 17652264 DOI: 10.1182/blood-2006-12-063222]
161. Sayan O, Akyol Erikci A, Ozturk A. The Efficacy of Helicobacter pylori eradication in the treatment of idiopathic thrombocytopenic purpura - the first study in Turkey. Acta Haematol 2006; 116: 146-149 [PMID: 16914913 DOI: 10.1159/000093648]
162. Suvajdziæ N, Stankoviæ B, Artiko V, Cvejiæ T, Bulat V, Bakrac M, Coloviæ M, Obradoviæ V, Atkinson HD. Helicobacter pylori eradication can induce platelet recovery in chronic idiopathic thrombocytopenic purpura. Platelets 2006; 17: 227-230 [PMID: 16769600 DOI: 10.1080/09537100500462487]
163. Kohda K, Kuga T, Kogawa K, Kanisawa Y, Koike K, Kuroiwa G, Hirayama Y, Sato Y, Niitsu Y. Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Br J Haematol 2002; 118: 584-588 [PMID: 12139750 DOI: 10.1046/j.1365-2141.2002.03612.x]
164. Kohda K, Niitsu Y. [Helicobacter pylori infection and idiopathic thrombocytopenic purpura]. Nihon Rinsho 2003; 61: 644-649 [PMID: 12718090]
165. Ando K, Shimamoto T, Tauchi T, Ito Y, Kuriyama Y, Gotoh A, Miyazawa K, Kimura Y, Kawai T, Ohyashiki K. Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura? Our experience and a literature review. Int J Hematol 2003; 77: 239-244 [PMID: 12731666 DOI: 10.1007/BF02983780]
166. Hashino S, Mori A, Suzuki S, Izumiyama K, Kahata K, Yonezumi M, Chiba K, Kondo T, Ota S, Toyashima N, Kato N, Tanaka J, Imamura M, Asaka M. Platelet recovery in patients with idiopathic thrombocytopenic purpura after eradication of Helicobacter pylori. Int J Hematol 2003; 77: 188-191 [PMID: 12627857 DOI: 10.1007/BF02983220]
167. Hino M, Yamane T, Park K, Takubo T, Ohta K, Kitagawa S, Higuchi K, Arakawa T. Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura. Ann Hematol 2003; 82: 30-32 [PMID: 12574961]
168. Kato A, Kato H, Hirashima N, Sakamoto T, Nukaya H, Ito K, Matsunaga S, Kondo H, Tanaka Y, Sakakibara K. [Evaluation of the efficacy of an Helicobacter pylori eradication treatment for idiopathic thrombocytopenic purpura patients]. Nihon Shokakibyo Gakkai Zasshi 2004; 101: 1209-1216 [PMID: 15570869]
169. Ando T, Tsuzuki T, Mizuno T, Minami M, Ina K, Kusugami K, Takamatsu J, Adachi K, El-Omar E, Ohta M, Goto H. Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura. Helicobacter 2004; 9: 443-452 [PMID: 15361084 DOI: 10.1111/ j.1083-4389.2004.00261.x]
170. Nomura S, Inami N, Kanazawa S. The effects of Helicobacter pylori eradication on chemokine production in patients with immune thrombocytopenic purpura. Eur J Haematol 2004; 72: 304-305 [PMID: 15089773 DOI: 10.1111/ j.1600-0609.2004.00220.x]
171. Sato R, Murakami K, Watanabe K, Okimoto T, Miyajima H, Ogata M, Ohtsuka E, Kodama M, Saburi Y, Fujioka T, Nasu M. Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura. Arch Intern Med 2004; 164: 1904-1907 [PMID: 15451766 DOI: 10.1001/archinte.164.17.1904]
172. Takahashi T, Yujiri T, Shinohara K, Inoue Y, Sato Y, Fujii Y, Okubo M, Zaitsu Y, Ariyoshi K, Nakamura Y, Nawata R, Oka Y, Shirai M, Tanizawa Y. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol 2004; 124: 91-96 [PMID: 14675413 DOI: 10.1046/j.1365-2141.2003.04735.x]
173. Fujimura K, Kuwana M, Kurata Y, Imamura M, Harada H, Sakamaki H, Teramura M, Koda K, Nomura S, Sugihara S, Shimomura T, Fujimoto TT, Oyashiki K, Ikeda Y. Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int J Hematol 2005; 81: 162-168 [PMID: 15765787 DOI: 10.1532/IJH97.04146]
174. Inaba T, Mizuno M, Take S, Suwaki K, Honda T, Kawai K, Fujita M, Tamura T, Yokota K, Oguma K, Okada H, Shiratori Y. Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan. Eur J Clin Invest 2005; 35: 214-219 [PMID: 15733077 DOI: 10.1111/j.1365-2362.2005.01471.x]
175. Tsutsumi Y, Kanamori H, Yamato H, Ehira N, Kawamura T, Umehara S, Mori A, Obara S, Ogura N, Tanaka J, Asaka M, Imamura M, Masauzi N. Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura. Ann Hematol 2005; 84: 807-811 [PMID: 16078036 DOI: 10.1007/s00277-005-1071-z]
176. Suzuki T, Matsushima M, Masui A, Watanabe K, Takagi A, Ogawa Y, Shirai T, Mine T. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial. Am J Gastroenterol 2005; 100: 1265-1270 [PMID: 15929755 DOI: 10.1111/j.1572-0241.2005.41641.x]
177. Asahi A, Kuwana M, Suzuki H, Hibi T, Kawakami Y, Ikeda Y. Effects of a Helicobacter pylori eradication regimen on antiplatelet autoantibody response in infected and uninfected patients with idiopathic thrombocytopenic purpura. Haematologica 2006; 91: 1436-1437 [PMID: 16963398]
178. Ishiyama M, Teramura M, Iwabe K, Kato T, Motoji T. Clonally expanded T-cells in the peripheral blood of patients with idiopathic Thrombocytopenic purpura and Helicobacter pylori infection. Int J Hematol 2006; 83: 147-151 [PMID: 16513533 DOI: 10.1532/IJH97.05119]
179. Satake M, Nishikawa J, Fukagawa Y, Akashi K, Okamoto T, Yoshida T, Hirano A, Maetani N, Iida Y, Sakaida I. The longterm efficacy of Helicobacter pylori eradication therapy in patients with idiopathic thrombocytopenic purpura. J Gastroenterol Hepatol 2007; 22: 2233-2237 [PMID: 17559384 DOI: 10.1111/j.1440-1746.2007.04845.x]
180. Kodama M, Kitadai Y, Ito M, Kai H, Masuda H, Tanaka S, Yoshihara M, Fujimura K, Chayama K. Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura. Helicobacter 2007; 12: 36-42 [PMID: 17241299 DOI: 10.1111/j.1523-5378.2007.00477. x]
181. Asahi A, Nishimoto T, Okazaki Y, Suzuki H, Masaoka T, Kawakami Y, Ikeda Y, Kuwana M. Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients. J Clin Invest 2008; 118: 2939-2949 [PMID: 18654664 DOI: 10.1172/JCI34496]
182. Suzuki T, Matsushima M, Shirakura K, Koike J, Masui A, Takagi A, Shirasugi Y, Ogawa Y, Shirai T, Mine T. Association of inflammatory cytokine gene polymorphisms with platelet recovery in idiopathic thrombocytopenic purpura patients after the eradication of Helicobacter pylori. Digestion 2008; 77: 73-78 [PMID: 18354254 DOI: 10.1159/000121392]
183. Tsumoto C, Tominaga K, Okazaki H, Tanigawa T, Yamagami H, Watanabe K, Nakao T, Koh K, Watanabe T, Fujiwara Y, Yamane T, Oshitani N, Hino M, Higuchi K, Arakawa T. Long-term efficacy of Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura: 7-year follow-up prospective study. Ann Hematol 2009; 88: 789-793 [PMID: 19096845 DOI: 10.1007/s00277-008-0667-5]
184. Sato R, Murakami K, Okimoto T, Watanabe K, Kodama M, Fujioka T. Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpura. J Gastroenterol 2011; 46: 991-997 [PMID: 21594563 DOI: 10.1007/s00535-011-0416-8]
185. Kikuchi T, Kobayashi T, Yamashita T, Ohashi K, Sakamaki H, Akiyama H. Eight-year follow-up of patients with immune thrombocytopenic purpura related to H. pyloriinfection. Platelets 2011; 22: 61-64 [PMID: 20942598 DOI: 10.3109/09537104.2010.515272]
186. Kong R, Qiu HC, Wu PF, Niu XH, Shen WX, Wang Y. [Clinical significance of Helicobacter pylori in pathogenesis of idiopathic thrombocytopenic purpura]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008; 16: 1222-1226 [PMID: 18928633]
187. Wu S, Li Y, Jian Z, Tang F. [Anti-Helicobacter pylori treatment in patients with idiopathic thrombocytopenic purpura]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2009; 34: 1251-1254 [PMID: 20045922]
188. Rostami N, Keshtkar-Jahromi M, Rahnavardi M, Keshtkar- Jahromi M, Esfahani FS. Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura: a controlled trial. Am J Hematol 2008; 83: 376-381 [PMID: 18183613 DOI: 10.1002/ajh.21125]
189. Payandeh M, Sohrabi N, Zare ME, Kansestani AN, Hashemian AH. Platelet Count Response to Helicobacter pylori Eradication in Iranian Patients with Idiopathic Thrombocytopenic Purpura. Mediterr J Hematol Infect Dis 2012; 4: e2012056 [PMID: 22973500 DOI: 10.4084/MJHID.2012.056]
190. Tag HS, Lee HS, Jung SH, Kim BK, Kim SB, Lee A, Lee JS, Shin SH, Kim YS. Effects of Helicobacter pylori eradication in patients with immune thrombocytopenic purpura. Korean J Hematol 2010; 45: 127-132 [PMID: 21120192 DOI: 10.5045/kjh.2010.45.2.127]
191. Campuzano-Maya G. Proof of an association between Helicobacter pylori and idiopathic thrombocytopenic purpura in Latin America. Helicobacter 2007; 12: 265-273 [PMID: 17493008 DOI: 10.1111/j.1523-5378.2007.00502.x]
192. Jackson SC, Beck P, Buret AG, O'Connor PM, Meddings J, Pineo G, Poon MC. Long term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpura. Int J Hematol 2008; 88: 212-218 [PMID: 18668306 DOI: 10.1007/s12185-008-0138-8]
193. Jarque I, Andreu R, Llopis I, De la Rubia J, Gomis F, Senent L, Jiménez C, Martín G, Martínez JA, Sanz GF, Ponce J, Sanz MA. Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol 2001; 115: 1002-1003 [PMID: 11843840 DOI: 10.1046/j.1365-2141.2001.03194.x]
194. Michel M, Khellaf M, Desforges L, Lee K, Schaeffer A, Godeau B, Bierling P. Autoimmune thrombocytopenic Purpura and Helicobacter pylori infection. Arch Intern Med 2002; 162: 1033-1036 [PMID: 11996614 DOI: 10.1001/archinte.162.9.1033]
195. Michel M, Cooper N, Jean C, Frissora C, Bussel JB. Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura? Blood 2004; 103: 890-896 [PMID: 12920031 DOI: 10.1182/blood-2003-03-0900]
196. Estrada-Gómez RA, Parra-Ortega I, Martínez-Barreda C, Ruiz-Argüelles GJ. Helicobacter pylori infection and thrombocytopenia: a single-institution experience in Mexico. Rev Invest Clin 2007; 59: 112-115 [PMID: 17633798]
197. Jaing TH, Yang CP, Hung IJ, Chiu CH, Chang KW. Efficacy of Helicobacter pylori eradication on platelet recovery in children with chronic idiopathic thrombocytopenic purpura. Acta Paediatr 2003; 92: 1153-1157 [PMID: 14632330 DOI: 10.1111/j.1651-2227.2003.tb02476.x]
198. Hayashi H, Okuda M, Aoyagi N, Yoshiyama M, Miyashiro E, Kounami S, Yoshikawa N. Helicobacter pylori infection in children with chronic idiopathic thrombocytopenic purpura. Pediatr Int 2005; 47: 292-295 [PMID: 15910453 DOI: 10.1111/j.1442-200x.2005.02058.x]
199. Hamidieh AA, Arzanian MT, Gachkar L, Pasha F. Helicobacter pylori infection in children with chronic idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2008; 30: 96-97 [PMID: 18176194 DOI: 10.1097/MPH.0b013e318161560000043426-200801000-00025]
200. Rajantie J, Klemola T. Helicobacter pylori and idiopathic thrombocytopenic purpura in children. Blood 2003; 101: 1660 [PMID: 12560248 DOI: 10.1182/blood-2002-10-3201]
201. Neefjes VM, Heijboer H, Tamminga RY. H. pylori infection in childhood chronic immune thrombocytopenic purpura. Haematologica 2007; 92: 576 [PMID: 17488677 DOI: 10.3324/haematol.10940]
202. Ferrara M, Capozzi L, Russo R. Effect of Helicobacter pylori eradication on platelet count in children with chronic idiopathic thrombocytopenic purpura. Hematology 2009; 14: 282-285 [PMID: 19843384 DOI: 10.1179/102453309X12473408860181]
203. Russo G, Miraglia V, Branciforte F, Matarese SM, Zecca M, Bisogno G, Parodi E, Amendola G, Giordano P, Jankovic M, Corti A, Nardi M, Farruggia P, Battisti L, Baronci C, Palazzi G, Tucci F, Ceppi S, Nobili B, Ramenghi U, De Mattia D, Notarangelo L. Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study. Pediatr Blood Cancer 2011; 56: 273-278 [PMID: 20830773 DOI: 10.1002/pbc.22770]
204. Scandellari R, Allemand E, Vettore S, Plebani M, Randi ML, Fabris F. Platelet response to Helicobacter pylori eradication therapy in adult chronic idiopathic thrombocytopenic purpura seems to be related to the presence of anticytotoxinassociated gene A antibodies. Blood Coagul Fibrinolysis 2009; 20: 108-113 [PMID: 19786938 DOI: 10.1097/MBC.0b013e32832315d800001721-200903000-00003]
205. Yetgin S, Demir H, Arslan D, Unal S, Koc¸ak N. Autoimmune thrombocytopenic purpura and Helicobacter pylori infection effectivity during childhood. Am J Hematol 2005; 78: 318 [PMID: 15795919 DOI: 10.1002/ajh.20302]
206. Loffredo G, Marzano MG, Migliorati R, Miele E, Menna F, Poggi V, Staiano A. The relationship between immune thrombocytopenic purpura and Helicobacter pylori infection in children: where is the truth? Eur J Pediatr 2007; 166: 1067-1068 [PMID: 17136353 DOI: 10.1007/s00431-006-0344-4]
207. Bisogno G, Errigo G, Rossetti F, Sainati L, Pusiol A, Da Dalt L, Colleselli P, Grotto P, Carli M. The role of Helicobacter pylori in children with chronic idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2008; 30: 53-57 [PMID: 18176181 DOI: 10.1097/MPH.0b013e318161561300043426-200801000-00012]
208. Treepongkaruna S, Sirachainan N, Kanjanapongkul S, Winaichatsak A, Sirithorn S, Sumritsopak R, Chuansumrit A. Absence of platelet recovery following Helicobacter pylori eradication in childhood chronic idiopathic thrombocytopenic purpura: a multi-center randomized controlled trial. Pediatr Blood Cancer 2009; 53: 72-77 [PMID: 19301380 DOI: 10.1002/pbc.21991]
209. Veres G, Karóczkai I, Bodánszky H, Marosi A, Magyarossi E, Dezsofi A, Arató A. [The role of Helicobacter pylori infection in children with chronic immune thrombocytopenic purpura]. Orv Hetil 2009; 150: 801-804 [PMID: 19362936 DOI: 10.1556/OH.2009.28581]
210. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010; 115: 168-186 [PMID: 19846889 DOI: 10.1182/blood-2009-06-225565]
211. Franchini M, Cruciani M, Mengoli C, Pizzolo G, Veneri D. Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis. J Antimicrob Chemother 2007; 60: 237-246 [PMID: 17561502 DOI: 10.1093/jac/dkm195]
212. Stasi R, Sarpatwari A, Segal JB, Osborn J, Evangelista ML, Cooper N, Provan D, Newland A, Amadori S, Bussel JB. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood 2009; 113: 1231-1240 [PMID: 18945961 DOI: 10.1182/blood-2008-07-167155]
213. Arnold DM, Bernotas A, Nazi I, Stasi R, Kuwana M, Liu Y, Kelton JG, Crowther MA. Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review. Haematologica 2009; 94: 850-856 [PMID: 19483158 DOI: 10.3324/haematol.2008.005348]
214. Wotherspoon AC. Which lessons can be drawn from study of Helicobacter pylori related MALT lymphoma? In: Hunt RH, Tytgat GN, editors. Helicobacter pylori Basic mechanims to clinical cure 2002. Dordrecht, The Netherlands: Kluwer Academic Publishers, 2002: 231-239
215. Isaacson PG, Spencer J, Finn T. Primary B-cell gastric lymphoma. Hum Pathol 1986; 17: 72-82 [PMID: 3510963 DOI: 10.1016/S0046-8177(86)80157-5]
216. Claviez A, Meyer U, Dominick C, Beck JF, Rister M, Tiemann M. MALT lymphoma in children: a report from the NHL-BFM Study Group. Pediatr Blood Cancer 2006; 47: 210-214 [PMID: 16123999 DOI: 10.1002/pbc.20575]
217. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 1999; 10: 1419-1432 [PMID: 10643532 DOI: 10.1023/A:1008375931236]
218. Isaacson P, Wright DH. Malignant lymphoma of mucosaassociated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983; 52: 1410-1416 [PMID: 6193858]
219. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175-1176 [PMID: 1682595 DOI: 10.1016/0140-6736(91)92035-Z]
220. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-577 [PMID: 8102719 DOI: 10.1016/0140-6736(93)914 09-F]
221. Isaacson PG, Diss TC, Wotherspoon AC, Barbazza R, De Boni M, Doglioni C. Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibodies. Gastroenterology 1999; 117: 750-751 [PMID: 10490369 DOI: 10.1016/S0016-5085(99)70483-X]
222. Wyatt JI, Rathbone BJ. Immune response of the gastric mucosa to Campylobacter pylori. Scand J Gastroenterol Suppl 1988; 142: 44-49 [PMID: 3166533 DOI: 10.3109/00365528809091712]
223. Stolte M, Eidt S. Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori? J Clin Pathol 1989; 42: 1269-1271 [PMID: 2613920 DOI: 10.1136/jcp.42.12.1269]
224. Genta RM, Hamner HW, Graham DY. Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution,and response to triple therapy. Hum Pathol 1993; 24: 577-583 [PMID: 8505036 DOI: 10.1016/0046-8177(93)90235-9]
225. Stolte M. Helicobacter pylori gastritis and gastric MALTlymphoma. Lancet 1992; 339: 745-746 [PMID: 1347613 DOI: 10.1016/0140-6736(92)90645-J]
226. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-6740 [PMID: 1458460]
227. Correa P. The biological model of gastric carcinogenesis. IARC Sci Publ 2004; (157): 301-310 [PMID: 15055303]
228. Nardone G, Rocco A, Malfertheiner P. Review article: helicobacter pylori and molecular events in precancerous gastric lesions. Aliment Pharmacol Ther 2004; 20: 261-270 [PMID: 15274662 DOI: 10.1111/j.1365-2036.2004.02075.x]
229. Crowe SE. Helicobacter infection, chronic inflammation, and the development of malignancy. Curr Opin Gastroenterol 2005; 21: 32-38 [PMID: 15687882]
230. Ando T, Goto Y, Maeda O, Watanabe O, Ishiguro K, Goto H. Causal role of Helicobacter pylori infection in gastric cancer. World J Gastroenterol 2006; 12: 181-186 [PMID: 16482615]
231. Ito M, Tanaka S, Kamada T, Haruma K, Chayama K. Causal role of Helicobacter pylori infection and eradication therapy in gastric carcinogenesis. World J Gastroenterol 2006; 12: 10-16 [PMID: 16440410]
232. Matysiak-Budnik T, Mégraud F. Helicobacter pylori infection and gastric cancer. Eur J Cancer 2006; 42: 708-716 [PMID: 16556496 DOI: 10.1016/j.ejca.2006.01.020]
233. Peek RM, Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol 2006; 208: 233-248 [PMID: 16362989 DOI: 10.1002/path.1868]
234. Tsuji S, Tsujii M, Murata H, Nishida T, Komori M, Yasumaru M, Ishii S, Sasayama Y, Kawano S, Hayashi N. Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms. World J Gastroenterol 2006; 12: 1671-1680 [PMID: 16586533]
235. Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosaassociated lymphoid tissue to Helicobacter pylori. Lancet 1993; 342: 571-574 [PMID: 8102718 DOI: 10.1016/0140-6736(93)91408-E]
236. Witherell HL, Hansen S, Jellum E, Orentreich N, Vogelman JH, Parsonnet J. Risk for gastric lymphoma in persons with CagA+ and CagA- Helicobacter pylori infection. J Infect Dis 1997; 176: 1641-1644 [PMID: 9395383 DOI: 10.1086/517346]
237. Peng H, Ranaldi R, Diss TC, Isaacson PG, Bearzi I, Pan L. High frequency of CagA+ Helicobacter pylori infection in high-grade gastric MALT B-cell lymphomas. J Pathol 1998; 185: 409-412 [PMID: 9828840]
238. Morgner A, Bayerdörffer E, Neubauer A, Stolte M. Gastric MALT lymphoma and its relationship to Helicobacter pylori infection: management and pathogenesis of the disease. Microsc Res Tech 2000; 48: 349-356 [PMID: 10738316]
239. Nardone G, Morgner A. Helicobacter pylori and gastric malignancies. Helicobacter 2003; 8 Suppl 1: 44-52 [PMID: 14617217 DOI: 10.1046/j.1523-5378.2003.00160.x]
240. Müller AM, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 2005; 84: 1-12 [PMID: 15480663 DOI: 10.1007/s00277-004-0939-7]
241. Isaacson PG. Gastric MALT lymphoma: from concept to cure. Ann Oncol 1999; 10: 637-645 [PMID: 10442184]
242. Minasian MC, Sharma A, Richman PI, Olver JM. Conjunctival MALT lymphoma: an usual cause of red eye. Postgrad Med J 1999; 75: 423-424 [PMID: 10474729]
243. Chan CC, Smith JA, Shen DF, Ursea R, LeHoang P, Grossniklaus HE. Helicobacter pylori (H. pylori) molecular signature in conjunctival mucosa-associated lymphoid tissue (MALT) lymphoma. Histol Histopathol 2004; 19: 1219-1226 [PMID: 15375765]
244. Nagashima R, Takeda H, Maeda K, Ohno S, Takahashi T. Regression of duodenal mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori. Gastroenterology 1996; 111: 1674-1678 [PMID: 8942749 DOI: 10.1016/ S0016-5085(96)70032-X]
245. Fischbach W, Tacke W, Greiner A, Konrad H. Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori. Lancet 1997; 349: 31-32 [PMID: 8988128 DOI: 10.1016/S0140-6736(05)62165-4]
246. Ochi M, Tominaga K, Okazaki H, Yamamori K, Wada T, Shiba M, Sasaki E, Watanabe T, Fujiwara Y, Oshitani N, Higuchi K, Arakawa T. Regression of primary low-grade mucosa-associated lymphoid tissue lymphoma of duodenum after long-term treatment with clarithromycin. Scand J Gastroenterol 2006; 41: 365-369 [PMID: 16497629 DOI: 10.1080/00365520500331224]
247. Alkan S, Karcher DS, Newman MA, Cohen P. Regression of salivary gland MALT lymphoma after treatment for Helicobacter pylori. Lancet 1996; 348: 268-269 [PMID: 8684218 DOI: 10.1016/S0140-6736(05)65578-X]
248. Berrebi D, Lescoeur B, Faye A, Faure C, Vilmer E, Peuchmaur M. MALT lymphoma of labial minor salivary gland in an immunocompetent child with a gastric Helicobacter pylori infection. J Pediatr 1998; 133: 290-292 [PMID: 9709725 DOI: 10.1016/S0022-3476(98)70239-2]
249. Nishimura M, Miyajima S, Okada N. Salivary gland MALT lymphoma associated with Helicobacter pylori infection in a patient with Sjögren's Syndrome. J Dermatol 2000; 27: 450-452 [PMID: 10935342]
250. Kania RE, Hartl DM, Badoual C, Le Maignan C, Brasnu DF. Primary mucosa-associated lymphoid tissue (MALT) lymphoma of the larynx. Head Neck 2005; 27: 258-262 [PMID: 15678477 DOI: 10.1002/hed.20149]
251. Gupte S, Nair R, Naresh KN, Borges AM, Soman CS, Gopal R, Advani SH. MALT lymphoma of nasal mucosa treated with antibiotics. Leuk Lymphoma 1999; 36: 195-197 [PMID: 10613465 DOI: 10.3109/10428199909145964]
252. Kawashima T, Nishimura H, Akiyama H, Hirai K, Yamagishi S, Okada D, Kinoshita H, Enomoto Y, Okamoto J, Nakajima Y, Takeuchi S, Iijima Y, Furuhata K, Nakayama K, Izumo T, Koizumi K, Shimizu K. Primary pulmonary mu-cosa- associated lymphoid tissue lymphoma combined with idiopathic thrombocytopenic purpura and amyloidoma in the lung. J Nippon Med Sch 2005; 72: 370-374 [PMID: 16415517 DOI: 10.1272/jnms.72.370]
253. Matsumoto T, Iida M, Shimizu M. Regression of mucosaassociated lymphoid-tissue lymphoma of rectum after eradication of Helicobacter pylori. Lancet 1997; 350: 115-116 [PMID: 9228971 DOI: 10.1016/S0140-6736(05)61818-1]
254. Inoue F, Chiba T. Regression of MALT lymphoma of the rectum after anti-H. pylori therapy in a patient negative for H. pylori. Gastroenterology 1999; 117: 514-515 [PMID: 10465640 DOI: 10.1053/gast.1999.0029900514b]
255. Coloviæ M, Hadzi-Djokiæ J, Cemerikiæ V, Coloviæ R, Jankoviæ G, Daciæ M. Primary MALT lymphoma of the kidney. Hematol Cell Ther 1999; 41: 229-232 [PMID: 10651124 DOI: 10.1007/s00282-999-0229-x]
256. van den Bosch J, Kropman RF, Blok P, Wijermans PW. Disappearance of a mucosa-associated lymphoid tissue (MALT) lymphoma of the urinary bladder after treatment for Helicobacter pylori. Eur J Haematol 2002; 68: 187-188 [PMID: 12028368 DOI: 10.1034/j.1600-0609.2002.01649.x]
257. Kröber SM, Aepinus C, Ruck P, Müller-Hermelink HK, Horny HP, Kaiserling E. Extranodal marginal zone B cell lymphoma of MALT type involving the mucosa of both the urinary bladder and stomach. J Clin Pathol 2002; 55: 554-557 [PMID: 12101213 DOI: 10.1136/jcp.55.7.554]
258. Keung YK, Higgs V, Albertson DA, Cappellari JO. Mucosaassociated lymhpoid tissue (MALT) lymphoma of the jejunum and Helicobacter pylori - chance association? Leuk Lymphoma 2003; 44: 1413-1416 [PMID: 12952237 DOI: 10.1080/1042819031000083064]
259. Shehab TM, Hsi ED, Poterucha JJ, Gunaratnam NT, Fontana RJ. Helicobacter pylori-associated gastric MALT lymphoma in liver transplant recipients. Transplantation 2001; 71: 1172-1175 [PMID: 11374421 DOI: 10.1097/00007890-200104270-00027]
260. Boissonnat P, El Bekkali Y, Salles G, Dumortier J, Roussoulieres A, Sebbag L, Gare J, Robin J, Ninet J, Bastien O. Regression of gastric lymphoma of mucosa associated with lymphoid tissue (MALT) following cardiac transplantation. J Heart Lung Transplant 2002; 21: 1044-1045 [PMID: 12231377 DOI: 10.1016/S1053-2498(01)00423-5]
261. Montalban C, Manzanal A, Boixeda D, Redondo C, Alvarez I, Calleja JL, Bellas C. Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: follow-up together with sequential molecular studies. Ann Oncol 1997; 8 Suppl 2: 37-39 [PMID: 9209638 DOI: 10.1093/annonc/8.suppl-2.S37]
262. Wündisch T, Mösch C, Neubauer A, Stolte M. Helicobacter pylori eradication in gastric mucosa-associated lymphoid tissue lymphoma: Results of a 196-patient series. Leuk Lymphoma 2006; 47: 2110-2114 [PMID: 17071484 DOI: 10.1080/10428190600783536]
263. Gupta V, Eden AJ, Mills MJ. Helicobacter pylori and autoimmune neutropenia. Clin Lab Haematol 2002; 24: 183-185 [PMID: 12067285 DOI: 10.1046/j.1365-2257.2002.00441.x]
264. Papadaki HA, Pontikoglou C, Stavroulaki E, Minadakis G, Eliopoulos DA, Pyrovolaki K, Skordilis P, Eliopoulos GD. High prevalence of Helicobacter pylori infection and monoclonal gammopathy of undetermined significance in patients with chronic idiopathic neutropenia. Ann Hematol 2005; 84: 317-320 [PMID: 15731921 DOI: 10.1007/s00277-004-0996-y]
265. Papadaki HA, Pontikoglou C, Eliopoulos DG, Pyrovolaki K, Spyridaki R, Eliopoulos GD. Helicobacter pylori infection is probably the cause of chronic idiopathic neutropenia (CIN)- associated splenomegaly. Am J Hematol 2006; 81: 142-144 [PMID: 16432851 DOI: 10.1002/ajh.20496]
266. Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome: a systematic review. JAMA 2006; 295: 1050-1057 [PMID: 16507806 DOI: 10.1001/jama.295.9.1050]
267. Cicconi V, Carloni E, Franceschi F, Nocente R, Silveri NG, Manna R, Servidei S, Bentivoglio AR, Gasbarrini A, Gasbarrini G. Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication. Am J Med 2001; 111: 163-164 [PMID: 11501549 DOI: 10.1016/ S0002-9343(01)00738-0]
268. Stasi R, Stipa E, Masi M, Oliva F, Sciarra A, Perrotti A, Olivieri M, Zaccari G, Gandolfo GM, Galli M. Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood 1994; 84: 4203-4208 [PMID: 7994034]
269. Lipp E, von Felten A, Sax H, Müller D, Berchtold P. Antibodies against platelet glycoproteins and antiphospholipid antibodies in autoimmune thrombocytopenia. Eur J Haematol 1998; 60: 283-288 [PMID: 9654157 DOI: 10.1111/j.1600-0609.1998.tb01041.x]
270. Macchi L, Rispal P, Clofent-Sanchez G, Pellegrin JL, Nurden P, Leng B, Nurden AT. Anti-platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome: their relationship with the observed thrombocytopenia. Br J Haematol 1997; 98: 336-341 [PMID: 9266930 DOI: 10.1046/j.1365-2141.1997.2243038.x]
271. Costen MT, Parkin BT, Davison CR, Crick MP. Central serous chorioretinopathy and antiphospholipid antibodies- -results of a pilot study. Eye (Lond) 2004; 18: 938 [PMID: 15002021 DOI: 10.1038/sj.eye.6701348]
272. Cotticelli L, Borrelli M, D'Alessio AC, Menzione M, Villani A, Piccolo G, Montella F, Iovene MR, Romano M. Central serous chorioretinopathy and Helicobacter pylori. Eur J Ophthalmol 2006; 16: 274-278 [PMID: 16703546]
273. International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003; 121: 749-757 [PMID: 12780789 DOI: 10.1046/j.1365-2141.2003.04355.x]
274. Osler W, McRae T. Diseases of the stomach. The principles and practice of medicine. New York: Appleton, 1920: 425
275. Twomey JJ, Laughter AH, Villanueva ND, Kao YS, Lidsky MD, Jordan PH. Gastric secretory and serologic studies on patients with neoplastic and immunologic disorders. Arch Intern Med 1971; 128: 746-749 [PMID: 5000872 DOI: 10.1001/archinte.1971.00310230076004]
276. Doberauer C, Sanner B, Henning B. Multiple myeloma involving the stomach with vitamin B12 deficiency. Eur J Gastroenterol Hepatol 1999; 11: 205-207 [PMID: 10102234 DOI: 10.1097/00042737-199902000-00024]
277. Chanarin I. The megaloblastic aenemias. 2nd ed. Oxford: Blackell Scientific Pubications, 1979
278. Elsborg L, Mosbech J. Pernicious anaemia as a risk factor in gastric cancer. Acta Med Scand 1979; 206: 315-318 [PMID: 506804 DOI: 10.1111/j.0954-6820.1979.tb13517.x]
279. Borch K. Epidemiologic, clinicopathologic, and economic aspects of gastroscopic screening of patients with pernicious anemia. Scand J Gastroenterol 1986; 21: 21-30 [PMID: 3952448 DOI: 10.3109/00365528609034616]
280. Hsing AW, Hansson LE, McLaughlin JK, Nyren O, Blot WJ, Ekbom A, Fraumeni JF. Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer 1993; 71: 745-750 [PMID: 8431855]
281. Carmel R. Megaloblastic anemias: disorders of impaired DNA synthesis. In: Greer JP, Foerster J, Lukens J, Rodgers GM, Paraskevas F, Glader G, editors. Wintrobe's Clinical Hema-tology. 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2004: 1367-1395
282. Goyal A, Langer JC, Zutter M, Swanson P, Kraus MD, Bartlett N, Shackelford GD, Longtine JA, Perlmutter DH. Primary gastric plasmacytoma: a rare cause of hypertrophic gastritis in an adolescent. J Pediatr Gastroenterol Nutr 1999; 29: 424-430 [PMID: 10512402 DOI: 10.1097/00005176-199910000-00010]
283. Ahmad A, Govil Y, Frank BB. Gastric mucosa-associated lymphoid tissue lymphoma. Am J Gastroenterol 2003; 98: 975-986 [PMID: 12809817 DOI: 10.1111/j.1572-0241.2003.07424.x]
284. Gonzalez Cueto D, Bruno S, Bustos Fernandez LM, Narbaitz M. [Gastric solitary plasmacytoma associated with +Helicobacter pylori infection]. Acta Gastroenterol Latinoam 1999; 29: 119-123 [PMID: 10533659]
285. Kato K, Sugitani M, Nagata T, Nishinarita S, Kawamura F, Takahashi Y, Ishii Y, Kawamura Y, Komuro S, Yanai M, Nemoto N, Arakawa Y. A case of gastric plasmacytoma associated with Helicobacter pylori infection: improvement of abnormal endoscopic and EUS findings after H. pylori eradication. Gastrointest Endosc 2001; 53: 352-355 [PMID: 11231401]
286. Papadaki HA, Skordilis P, Minadakis G, Roussomoustakaki M, Katrinakis G, Psyllaki M, Tzardi M, Kouroumalis E, Eliopoulos GD. Complete regression of primary gastric plasmacytoma following Helicobacter pylori eradication. Ann Hematol 2003; 82: 589-592 [PMID: 12898183 DOI: 10.1007/s00277-003-0701-6]
287. Tursi A, Modeo ME. Monoclonal gammopathy of undetermined significance predisposing to Helicobacter pylori-related gastric mucosa-associated lymphoid tissue lymphoma. J Clin Gastroenterol 2002; 34: 147-149 [PMID: 11782609 DOI: 10.1097/00004836-200202000-00009]
288. Braggio E, Fonseca R. Genomic abnormalities of Waldenström macroglobulinemia and related low-grade B-cell lymphomas. Clin Lymphoma Myeloma Leuk 2013; 13: 198-201 [PMID: 23477936 DOI: 10.1016/j.clml.2013.02.015]
289. Feingold ML, Goldstein MJ, Lieberman PH. Multiple myeloma involving the stomach. Report of a case with gastroscopic observations. Gastrointest Endosc 1969; 16: 107-110 [PMID: 5352281]
290. Kyle RA, Pierre RV, Bayrd ED. Multiple myeloma and acute myelomonocytic leukemia. N Engl J Med 1970; 283: 1121-1125 [PMID: 5273282 DOI: 10.1056/NEJM197011192832101]
291. Law IP, Blom J. Second malignancies in patients with multiple myeloma. Oncology 1977; 34: 20-24 [PMID: 405642 DOI: 10.1159/000225175]
292. Bergsagel DE, Bailey AJ, Langley GR, MacDonald RN, White DF, Miller AB. The chemotherapy on plasma-cell myeloma and the incidence of acute leukemia. N Engl J Med 1979; 301: 743-748 [PMID: 481481 DOI: 10.1056/NEJM197910043011402]
293. Nelson RS. Tumores malignos del estómago distintos del carcinoma. In: Berk JE, Haubrich WS, Kalser M, Roth JLA, Vilardell F, editors. Gastroenterología Henry Bockus. 3rd ed. Barcelona, España: Salvat Editores, 1980: 1058-1078
294. Brouet JC, Fermand JP, Laurent G, Grange MJ, Chevalier A, Jacquillat C, Seligmann M. The association of chronic lymphocytic leukaemia and multiple myeloma: a study of eleven patients. Br J Haematol 1985; 59: 55-66 [PMID: 3882132 DOI: 10.1111/j.1365-2141.1985.tb02963.x]
295. Kaufmann H, Ackermann J, Nösslinger T, Krömer E, Zojer N, Schreiber S, Urbauer E, Heinz R, Ludwig H, Huber H, Drach J. Absence of clonal chromosomal relationship between concomitant B-CLL and multiple myeloma - a report on two cases. Ann Hematol 2001; 80: 474-478 [PMID: 11563594 DOI: 10.1007/s002770100328]
296. Wöhrer S, Isaacson PG, Raderer M. Complete regression of primary gastric plasmacytoma following Helicobacter pylori eradication. Ann Hematol 2004; 83: 666 [PMID: 15449033 DOI: 10.1007/s00277-004-0903-6]
297. Wöhrer S, Raderer M, Streubel B, Chott A, Drach J. Concomitant occurrence of MALT lymphoma and multiple myeloma. Ann Hematol 2004; 83: 600-603 [PMID: 15083336 DOI: 10.1007/s00277-004-0870-y]
298. Malik AA, Ganti AK, Potti A, Levitt R, Hanley JF. Role of Helicobacter pylori infection in the incidence and clinical course of monoclonal gammopathy of undetermined significance. Am J Gastroenterol 2002; 97: 1371-1374 [PMID: 12094852 DOI: 10.1111/j.1572-0241.2002.05668.x]
299. Wolkersdörfer GW, Haase M, Morgner A, Baretton G, Miehlke S. Monoclonal gammopathy of undetermined significance and Russell body formation in Helicobacter pylori gastritis. Helicobacter 2006; 11: 506-510 [PMID: 16961813 DOI: 10.1111/j.1523-5378.2006.00443.x]
300. Rajkumar SV, Kyle RA, Plevak MF, Murray JA, Therneau TM. Helicobacter pylori infection and monoclonal gammopathy of undetermined significance. Br J Haematol 2002; 119: 706-708 [PMID: 12437647 DOI: 10.1046/j.1365-2141.2002.03912.x]
301. Gok F, Ugur Y, Ozen S, Dagdeviren A. Pathogenesis-related adhesion molecules in Henoch-Schonlein vasculitis. Rheumatol Int 2008; 28: 313-316 [PMID: 17701178 DOI: 10.1007/s00296-007-0437-z]
302. Reinauer S, Megahed M, Goerz G, Ruzicka T, Borchard F, Susanto F, Reinauer H. Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection. J Am Acad Dermatol 1995; 33: 876-879 [PMID: 7593800 DOI: 10.1016/019 0-9622(95)90426-3]
303. Cecchi R, Torelli E. Schönlein-Henoch purpura in association with duodenal ulcer and gastric Helicobacter pylori infection. J Dermatol 1998; 25: 482-484 [PMID: 9714985]
304. Novák J, Szekanecz Z, Sebesi J, Takáts A, Demeter P, Bene L, Sipka S, Csiki Z. Elevated levels of anti-Helicobacter pylori antibodies in Henoch-Schönlein purpura. Autoimmunity 2003; 36: 307-311 [PMID: 14567560 DOI: 10.1080/08916930232000114535]
305. Fu KI, Yagi S, Mashimo Y, Sugitani K, Imamaki K, Yanagisawa M, Maekawa S, Morimoto Y, Fujimori T. Regression of Helicobacter pylori-negative duodenal ulcers complicated by Schonlein-Henoch purpura with H. pylori eradication therapy: the first report. Dig Dis Sci 2005; 50: 381-384 [PMID: 15745104 DOI: 10.1007/s10620-005-1614-0]
306. Mytinger JR, Patterson JW, Thibault ES, Webb J, Saulsbury FT. Henoch-Schönlein purpura associated with Helicobacter pylori infection in a child. Pediatr Dermatol 2008; 25: 630-632 [PMID: 19067870 DOI: 10.1111/j.1525-1470.2008.00786.x]
307. Grivceva-Panovska V, Grivceva Stardelova K, Serafimoski V. Henoch-Schönlein purpura in an adult patient: extragastric, cutaneous manifestation of helicobacter pylori infection. Prilozi 2008; 29: 291-301 [PMID: 18709017]
308. Hoshino C. Adult onset Schönlein-Henoch purpura associated with Helicobacter pylori infection. Intern Med 2009; 48: 847-851 [PMID: 19443983 DOI: 10.2169/internalmedicine.48.1718]
309. Mozrzymas R, d'Amore ES, Montini G, Guariso G. Schön-lein- Henoch vasculitis and chronic Helicobacter pylori associated gastritis and duodenal ulcer: a case report. Pediatr Med Chir 1997; 19: 467-468 [PMID: 9595588]
310. Shin JI, Koh H, Lee JS. Henoch-Schönlein purpura associated with helicobacter pylori infection: the pathogenic roles of IgA, C3, and cryoglobulins? Pediatr Dermatol 2009; 26: 768-769 [PMID: 20199470 DOI: 10.1111/j.1525-1470.2009.01039.x]
311. Lehtinen M, Ogmundsdottir HM, Bloigu A, Hakulinen T, Hemminki E, Gudnadottir M, Kjartansdottir A, Paavonen J, Pukkala E, Tulinius H, Lehtinen T, Koskela P. Associations between three types of maternal bacterial infection and risk of leukemia in the offspring. Am J Epidemiol 2005; 162: 662-667 [PMID: 16120707 DOI: 10.1093/aje/kwi261]
312. Diamantidis MD, Ioannidou-Papagiannaki E, Kountouras J, Mandala E, Tsapournas G, Frida-Michailidou I, Klonizakis P, Zavos C, Haralambidou-Vranitsa S, Vlachaki E, Parapanisiou E, Klonizakis I. High prevalence of Helicobacter pylori infection in Greek patients with myelodysplastic syndromes. Acta Haematol 2010; 124: 141-149 [PMID: 20938168 DOI: 10.1159/000319629]
313. Kawamata T, Tojo A. Helicobacter pylori-induced thrombocytosis clinically indistinguishable from essential thrombocythemia. Leuk Lymphoma 2012; 53: 1423-1424 [PMID: 22204454 DOI: 10.3109/10428194.2011.653787]
314. Fioredda F, Haupt R, Castagnola E, Barabino A, Micalizzi C, Dini G, Dufour C. Helicobacter pylori-associated large gastric ulcer during treatment for childhood leukemia. J Pediatr Hematol Oncol 2002; 24: 759-762 [PMID: 12468920 DOI: 10.1097/00043426-200212000-00016]
315. Dolatkhah R, Khoshbaten M, Asvadi Kermani I, Reza Bonyadi M, Ghojazadeh M, Sanaat Z, Asvadi Kermani T, Dolatkhah N. Upper gastrointestinal bleedings in patients with hereditary coagulation disorders in Northwest of Iran: prevalence of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 2011; 23: 1172-1177 [PMID: 21904206 DOI: 10.1097/MEG.0b013e32834b0e7a]
316. Schulman S, Rehnberg AS, Hein M, Hegedus O, Lindmarker P, Hellström PM. Helicobacter pylori causes gastrointestinal hemorrhage in patients with congenital bleeding disorders. Thromb Haemost 2003; 89: 741-746 [PMID: 12669130]
317. Braden B, Wenke A, Karich HJ, Dietrich CF, Scharrer I, Caspary WF, Lembcke B. Risk of gastrointestinal bleeding associated with Helicobacter pylori infection in patients with hemophilia or von Willebrand's syndrome. Helicobacter 1998; 3: 184-187 [PMID: 9731989 DOI: 10.1046/j.1523-5378.1998.08052.x]
318. Tincani E, Bertoni G, Silingardi M, Ghirarduzzi A, Bedogni G, Iori I. Helicobacter pylori, a frequent and potentially dangerous guest in the gastroduodenal mucosa of anticoagulated patients. Am J Med 2000; 108: 165-167 [PMID: 11126310 DOI: 10.1016/S0002-9343(99)00412-X]
319. Beswick EJ, Suarez G, Reyes VE. H pylori and host interactions that influence pathogenesis. World J Gastroenterol 2006; 12: 5599-5605 [PMID: 17007010]
320. Carmel R. Megaloblastic anemias: disorders of impaired DNA synthesis. In: Greer JP, Arber DA, Glader B, List AF, Means RTJ, Paraskevas F, Rodgers GM, editors. Wintrobe' s Clinical Hematology. 13 ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2013: 927-953
321. Karpatkin S. Autoimmune (idiopathic) thrombocytopenic purpura. Lancet 1997; 349: 1531-1536 [PMID: 9167472 DOI: 10.1016/S0140-6736(96)12118-8]
322. Shiu MH, Karas M, Nisce L, Lee BJ, Filippa DA, Lieberman PH. Management of primary gastric lymphoma. Ann Surg 1982; 195: 196-202 [PMID: 7034661 DOI: 10.1097/00000658-198202000-00013]
323. Gisbert JP, Calvet X. Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma. Aliment Pharmacol Ther 2011; 34: 1047-1062 [PMID: 21919927 DOI: 10.1111/j.1365-2036.2011.04839.x]